Elanco Animal Health Inc·4

Jun 30, 4:28 PM ET

VanHimbergen Robert M 4

Research Summary

AI-generated summary

Updated

Elanco (ELAN) CFO Robert M. VanHimbergen Receives Award

What Happened Robert M. VanHimbergen, Elanco's Executive Vice President and Chief Financial Officer, was granted 8.019 deferred stock units on 2026-06-26. The units are reported at $24.57 each for a notional value of $197. This transaction is an award/grant (derivative) under Elanco’s compensation plan, not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-06-26; filing date: 2026-06-30.
  • Transaction type/code: Award (A) — 8.019 deferred stock units @ $24.57 = $197 (derivative).
  • Shares owned after transaction: not specified in the filing.
  • Plan: Executive Deferral and Stock Match Plan (per filing footnotes).
  • Footnotes: F1 — each deferred stock unit (DSU) equals the right to one share or cash equivalent; F2 — DSUs settle in cash or shares after termination or in a specified future year per the plan.
  • Timeliness: filing reports the 6/26/2026 transaction on 6/30/2026; the Form 4 does not flag additional timing details.

Context This was a compensation-related grant of deferred stock units (a derivative award). DSUs do not typically convey immediate ownership — they represent a future right to receive shares or cash according to the plan’s settlement rules — and are common in executive pay packages. The dollar value here is small (~$197) and is likely a routine compensation or deferral accounting entry rather than a signal of insider buying or selling intention.